Abstract
Global treatment responder analysis demonstrates clinically relevant effect of velmanase alfa long term enzyme replacement therapy for alpha mannosidosis, in a phase III randomized placebo controlled trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have